Dr. Silberg, MD, PhD, is a physician-scientist specializing in gastroenterology, internal medicine, and mucosal immunology. She serves as Chief Scientific Officer at Beyond Celiac, where she leads the organization’s research strategy and also chairs and co-chairs its Scientific Advisory Board and coalition initiatives. Her clinical focus includes gastrointestinal inflammation and immune-mediated digestive health, upper gastrointestinal motility, and translational drug development in gastroenterology. Her research interests include mucosal biology, gut microbiome science, and the development of novel gastrointestinal therapeutics. In addition to her role at Beyond Celiac, Dr. Silberg serves on the Board of Directors and as a scientific advisor to Ellodi Pharmaceuticals and advises multiple life sciences and biotechnology companies. Her achievements include senior global clinical development leadership roles at Takeda/Shire and AstraZeneca, service on national scientific and regulatory gastroenterology committees, and leadership of NIH-funded research as a former faculty member and principal investigator in the Division of Gastroenterology at the University of Pennsylvania Health System. Dr. Silberg earned her MD from Albert Einstein College of Medicine and her PhD in Immunology from Wayne State University School of Medicine. She completed her internal medicine residency and gastroenterology fellowship at the University of Pennsylvania Health System.
Chief Scientific Officer
Medical School
1985 – 1989
Residency
1989 – 1992
Fellowship
1992 – 1995